nodes	percent_of_prediction	percent_of_DWPC	metapath
Zaleplon—CYP3A4—Temozolomide—melanoma	0.139	0.285	CbGbCtD
Zaleplon—CYP3A7—Docetaxel—melanoma	0.0891	0.183	CbGbCtD
Zaleplon—CYP3A7-CYP3A51P—Docetaxel—melanoma	0.0891	0.183	CbGbCtD
Zaleplon—CYP3A4—Vemurafenib—melanoma	0.076	0.156	CbGbCtD
Zaleplon—CYP3A5—Docetaxel—melanoma	0.0668	0.138	CbGbCtD
Zaleplon—CYP3A4—Docetaxel—melanoma	0.0261	0.0537	CbGbCtD
Zaleplon—TSPO—hindlimb—melanoma	0.00398	0.163	CbGeAlD
Zaleplon—TSPO—appendage—melanoma	0.00342	0.14	CbGeAlD
Zaleplon—TSPO—hair follicle—melanoma	0.00203	0.083	CbGeAlD
Zaleplon—TSPO—blood vessel—melanoma	0.0019	0.0779	CbGeAlD
Zaleplon—TSPO—neck—melanoma	0.00136	0.0557	CbGeAlD
Zaleplon—Dysphagia—Temozolomide—melanoma	0.00124	0.00257	CcSEcCtD
Zaleplon—Neuropathy—Docetaxel—melanoma	0.00123	0.00256	CcSEcCtD
Zaleplon—Pneumonia—Dactinomycin—melanoma	0.00123	0.00255	CcSEcCtD
Zaleplon—Oesophagitis—Docetaxel—melanoma	0.0012	0.00249	CcSEcCtD
Zaleplon—Decreased appetite—Vemurafenib—melanoma	0.0012	0.00248	CcSEcCtD
Zaleplon—Bronchitis—Temozolomide—melanoma	0.00119	0.00247	CcSEcCtD
Zaleplon—Stomatitis—Dactinomycin—melanoma	0.00119	0.00247	CcSEcCtD
Zaleplon—Gastrointestinal disorder—Vemurafenib—melanoma	0.00119	0.00247	CcSEcCtD
Zaleplon—AOX1—eye—melanoma	0.00119	0.0485	CbGeAlD
Zaleplon—Constipation—Vemurafenib—melanoma	0.00118	0.00244	CcSEcCtD
Zaleplon—Hypoaesthesia—Bleomycin—melanoma	0.00117	0.00242	CcSEcCtD
Zaleplon—Dysuria—Temozolomide—melanoma	0.00116	0.0024	CcSEcCtD
Zaleplon—Hyperglycaemia—Carmustine—melanoma	0.00116	0.0024	CcSEcCtD
Zaleplon—Pneumonia—Carmustine—melanoma	0.00115	0.00238	CcSEcCtD
Zaleplon—Pollakiuria—Temozolomide—melanoma	0.00114	0.00237	CcSEcCtD
Zaleplon—Erectile dysfunction—Temozolomide—melanoma	0.00114	0.00236	CcSEcCtD
Zaleplon—Depression—Carmustine—melanoma	0.00114	0.00236	CcSEcCtD
Zaleplon—Photosensitivity reaction—Temozolomide—melanoma	0.00113	0.00234	CcSEcCtD
Zaleplon—Weight increased—Temozolomide—melanoma	0.00113	0.00234	CcSEcCtD
Zaleplon—Weight decreased—Temozolomide—melanoma	0.00112	0.00232	CcSEcCtD
Zaleplon—Neuropathy peripheral—Carmustine—melanoma	0.00112	0.00232	CcSEcCtD
Zaleplon—Hyperglycaemia—Temozolomide—melanoma	0.00112	0.00232	CcSEcCtD
Zaleplon—Stomatitis—Carmustine—melanoma	0.00111	0.00231	CcSEcCtD
Zaleplon—Pneumonia—Temozolomide—melanoma	0.00111	0.0023	CcSEcCtD
Zaleplon—Depression—Temozolomide—melanoma	0.0011	0.00228	CcSEcCtD
Zaleplon—Thrombophlebitis—Docetaxel—melanoma	0.0011	0.00228	CcSEcCtD
Zaleplon—Body temperature increased—Vemurafenib—melanoma	0.00109	0.00226	CcSEcCtD
Zaleplon—Neuropathy peripheral—Temozolomide—melanoma	0.00108	0.00224	CcSEcCtD
Zaleplon—Swelling—Docetaxel—melanoma	0.00108	0.00224	CcSEcCtD
Zaleplon—Stomatitis—Temozolomide—melanoma	0.00108	0.00223	CcSEcCtD
Zaleplon—Deafness—Docetaxel—melanoma	0.00107	0.00221	CcSEcCtD
Zaleplon—Chills—Bleomycin—melanoma	0.00105	0.00219	CcSEcCtD
Zaleplon—Hepatobiliary disease—Temozolomide—melanoma	0.00104	0.00217	CcSEcCtD
Zaleplon—Alopecia—Bleomycin—melanoma	0.00104	0.00215	CcSEcCtD
Zaleplon—Hallucination—Carmustine—melanoma	0.00102	0.00212	CcSEcCtD
Zaleplon—Hypoaesthesia—Carmustine—melanoma	0.00102	0.00212	CcSEcCtD
Zaleplon—TSPO—eye—melanoma	0.00101	0.0414	CbGeAlD
Zaleplon—Oedema peripheral—Carmustine—melanoma	0.00101	0.0021	CcSEcCtD
Zaleplon—TSPO—retina—melanoma	0.001	0.0411	CbGeAlD
Zaleplon—Dermatitis bullous—Docetaxel—melanoma	0.000997	0.00207	CcSEcCtD
Zaleplon—Asthenia—Vemurafenib—melanoma	0.000989	0.00205	CcSEcCtD
Zaleplon—Visual impairment—Carmustine—melanoma	0.000989	0.00205	CcSEcCtD
Zaleplon—Hallucination—Temozolomide—melanoma	0.000987	0.00204	CcSEcCtD
Zaleplon—Hypoaesthesia—Temozolomide—melanoma	0.000987	0.00204	CcSEcCtD
Zaleplon—Chills—Dactinomycin—melanoma	0.000984	0.00204	CcSEcCtD
Zaleplon—Oedema peripheral—Temozolomide—melanoma	0.000977	0.00202	CcSEcCtD
Zaleplon—Pruritus—Vemurafenib—melanoma	0.000975	0.00202	CcSEcCtD
Zaleplon—Alopecia—Dactinomycin—melanoma	0.000969	0.00201	CcSEcCtD
Zaleplon—Eye disorder—Carmustine—melanoma	0.000959	0.00199	CcSEcCtD
Zaleplon—Visual impairment—Temozolomide—melanoma	0.000955	0.00198	CcSEcCtD
Zaleplon—Ill-defined disorder—Bleomycin—melanoma	0.000949	0.00197	CcSEcCtD
Zaleplon—Anaemia—Bleomycin—melanoma	0.000946	0.00196	CcSEcCtD
Zaleplon—AOX1—mammalian vulva—melanoma	0.000941	0.0385	CbGeAlD
Zaleplon—Migraine—Docetaxel—melanoma	0.000938	0.00194	CcSEcCtD
Zaleplon—Eye disorder—Temozolomide—melanoma	0.000927	0.00192	CcSEcCtD
Zaleplon—Tinnitus—Temozolomide—melanoma	0.000924	0.00192	CcSEcCtD
Zaleplon—Malaise—Bleomycin—melanoma	0.000923	0.00191	CcSEcCtD
Zaleplon—GABRB3—eye—melanoma	0.000919	0.0376	CbGeAlD
Zaleplon—Dizziness—Vemurafenib—melanoma	0.000911	0.00189	CcSEcCtD
Zaleplon—Alopecia—Carmustine—melanoma	0.000907	0.00188	CcSEcCtD
Zaleplon—Mental disorder—Carmustine—melanoma	0.000899	0.00186	CcSEcCtD
Zaleplon—Ataxia—Docetaxel—melanoma	0.000896	0.00186	CcSEcCtD
Zaleplon—Immune system disorder—Temozolomide—melanoma	0.000896	0.00186	CcSEcCtD
Zaleplon—Malnutrition—Carmustine—melanoma	0.000893	0.00185	CcSEcCtD
Zaleplon—Chills—Temozolomide—melanoma	0.00089	0.00184	CcSEcCtD
Zaleplon—Ill-defined disorder—Dactinomycin—melanoma	0.000885	0.00184	CcSEcCtD
Zaleplon—Anaemia—Dactinomycin—melanoma	0.000882	0.00183	CcSEcCtD
Zaleplon—TSPO—skin of body—melanoma	0.000881	0.0361	CbGeAlD
Zaleplon—Liver function test abnormal—Docetaxel—melanoma	0.00088	0.00182	CcSEcCtD
Zaleplon—Alopecia—Temozolomide—melanoma	0.000876	0.00182	CcSEcCtD
Zaleplon—Dry skin—Docetaxel—melanoma	0.000874	0.00181	CcSEcCtD
Zaleplon—Myalgia—Bleomycin—melanoma	0.000871	0.00181	CcSEcCtD
Zaleplon—Chest pain—Bleomycin—melanoma	0.000871	0.00181	CcSEcCtD
Zaleplon—Orthostatic hypotension—Docetaxel—melanoma	0.000871	0.0018	CcSEcCtD
Zaleplon—Rash—Vemurafenib—melanoma	0.000869	0.0018	CcSEcCtD
Zaleplon—Mental disorder—Temozolomide—melanoma	0.000869	0.0018	CcSEcCtD
Zaleplon—Dermatitis—Vemurafenib—melanoma	0.000868	0.0018	CcSEcCtD
Zaleplon—Back pain—Carmustine—melanoma	0.000864	0.00179	CcSEcCtD
Zaleplon—Headache—Vemurafenib—melanoma	0.000863	0.00179	CcSEcCtD
Zaleplon—Malnutrition—Temozolomide—melanoma	0.000863	0.00179	CcSEcCtD
Zaleplon—Breast disorder—Docetaxel—melanoma	0.000861	0.00179	CcSEcCtD
Zaleplon—Discomfort—Bleomycin—melanoma	0.000861	0.00178	CcSEcCtD
Zaleplon—Malaise—Dactinomycin—melanoma	0.000861	0.00178	CcSEcCtD
Zaleplon—Aspartate aminotransferase increased—Docetaxel—melanoma	0.000858	0.00178	CcSEcCtD
Zaleplon—Dysgeusia—Temozolomide—melanoma	0.000845	0.00175	CcSEcCtD
Zaleplon—Confusional state—Bleomycin—melanoma	0.000842	0.00175	CcSEcCtD
Zaleplon—Alanine aminotransferase increased—Docetaxel—melanoma	0.000841	0.00174	CcSEcCtD
Zaleplon—Tremor—Carmustine—melanoma	0.000837	0.00173	CcSEcCtD
Zaleplon—Anaphylactic shock—Bleomycin—melanoma	0.000835	0.00173	CcSEcCtD
Zaleplon—Oedema—Bleomycin—melanoma	0.000835	0.00173	CcSEcCtD
Zaleplon—Back pain—Temozolomide—melanoma	0.000835	0.00173	CcSEcCtD
Zaleplon—Anaemia—Carmustine—melanoma	0.000825	0.00171	CcSEcCtD
Zaleplon—Dysphagia—Docetaxel—melanoma	0.000824	0.00171	CcSEcCtD
Zaleplon—Agitation—Carmustine—melanoma	0.000821	0.0017	CcSEcCtD
Zaleplon—Nausea—Vemurafenib—melanoma	0.000819	0.0017	CcSEcCtD
Zaleplon—Myalgia—Dactinomycin—melanoma	0.000812	0.00168	CcSEcCtD
Zaleplon—Tremor—Temozolomide—melanoma	0.000809	0.00168	CcSEcCtD
Zaleplon—TSPO—mammalian vulva—melanoma	0.000803	0.0329	CbGeAlD
Zaleplon—Discomfort—Dactinomycin—melanoma	0.000803	0.00166	CcSEcCtD
Zaleplon—Angina pectoris—Docetaxel—melanoma	0.000802	0.00166	CcSEcCtD
Zaleplon—Ill-defined disorder—Temozolomide—melanoma	0.000801	0.00166	CcSEcCtD
Zaleplon—Anaemia—Temozolomide—melanoma	0.000798	0.00165	CcSEcCtD
Zaleplon—Anorexia—Bleomycin—melanoma	0.000796	0.00165	CcSEcCtD
Zaleplon—Agitation—Temozolomide—melanoma	0.000793	0.00164	CcSEcCtD
Zaleplon—Angioedema—Temozolomide—melanoma	0.000789	0.00163	CcSEcCtD
Zaleplon—Hypotension—Bleomycin—melanoma	0.00078	0.00162	CcSEcCtD
Zaleplon—Oedema—Dactinomycin—melanoma	0.000779	0.00161	CcSEcCtD
Zaleplon—Malaise—Temozolomide—melanoma	0.000778	0.00161	CcSEcCtD
Zaleplon—Vertigo—Temozolomide—melanoma	0.000775	0.00161	CcSEcCtD
Zaleplon—Hypertension—Carmustine—melanoma	0.000771	0.0016	CcSEcCtD
Zaleplon—Palpitations—Temozolomide—melanoma	0.000763	0.00158	CcSEcCtD
Zaleplon—Musculoskeletal discomfort—Bleomycin—melanoma	0.000761	0.00158	CcSEcCtD
Zaleplon—Myalgia—Carmustine—melanoma	0.00076	0.00158	CcSEcCtD
Zaleplon—Chest pain—Carmustine—melanoma	0.00076	0.00158	CcSEcCtD
Zaleplon—Anxiety—Carmustine—melanoma	0.000758	0.00157	CcSEcCtD
Zaleplon—Paraesthesia—Bleomycin—melanoma	0.00075	0.00155	CcSEcCtD
Zaleplon—Weight increased—Docetaxel—melanoma	0.00075	0.00155	CcSEcCtD
Zaleplon—Weight decreased—Docetaxel—melanoma	0.000745	0.00154	CcSEcCtD
Zaleplon—Hypertension—Temozolomide—melanoma	0.000745	0.00154	CcSEcCtD
Zaleplon—Dyspnoea—Bleomycin—melanoma	0.000744	0.00154	CcSEcCtD
Zaleplon—Anorexia—Dactinomycin—melanoma	0.000742	0.00154	CcSEcCtD
Zaleplon—Pneumonia—Docetaxel—melanoma	0.000739	0.00153	CcSEcCtD
Zaleplon—Confusional state—Carmustine—melanoma	0.000735	0.00152	CcSEcCtD
Zaleplon—Arthralgia—Temozolomide—melanoma	0.000735	0.00152	CcSEcCtD
Zaleplon—Myalgia—Temozolomide—melanoma	0.000735	0.00152	CcSEcCtD
Zaleplon—Anxiety—Temozolomide—melanoma	0.000732	0.00152	CcSEcCtD
Zaleplon—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—melanoma	0.00073	0.00151	CcSEcCtD
Zaleplon—Oedema—Carmustine—melanoma	0.000729	0.00151	CcSEcCtD
Zaleplon—Discomfort—Temozolomide—melanoma	0.000726	0.0015	CcSEcCtD
Zaleplon—Decreased appetite—Bleomycin—melanoma	0.000726	0.0015	CcSEcCtD
Zaleplon—Neuropathy peripheral—Docetaxel—melanoma	0.00072	0.00149	CcSEcCtD
Zaleplon—Dry mouth—Temozolomide—melanoma	0.000719	0.00149	CcSEcCtD
Zaleplon—Stomatitis—Docetaxel—melanoma	0.000716	0.00148	CcSEcCtD
Zaleplon—Pain—Bleomycin—melanoma	0.000714	0.00148	CcSEcCtD
Zaleplon—Conjunctivitis—Docetaxel—melanoma	0.000714	0.00148	CcSEcCtD
Zaleplon—Tachycardia—Carmustine—melanoma	0.000711	0.00147	CcSEcCtD
Zaleplon—Confusional state—Temozolomide—melanoma	0.00071	0.00147	CcSEcCtD
Zaleplon—Musculoskeletal discomfort—Dactinomycin—melanoma	0.00071	0.00147	CcSEcCtD
Zaleplon—Anaphylactic shock—Temozolomide—melanoma	0.000704	0.00146	CcSEcCtD
Zaleplon—Oedema—Temozolomide—melanoma	0.000704	0.00146	CcSEcCtD
Zaleplon—Anorexia—Carmustine—melanoma	0.000695	0.00144	CcSEcCtD
Zaleplon—Hepatobiliary disease—Docetaxel—melanoma	0.000695	0.00144	CcSEcCtD
Zaleplon—Epistaxis—Docetaxel—melanoma	0.000693	0.00144	CcSEcCtD
Zaleplon—Nervous system disorder—Temozolomide—melanoma	0.000691	0.00143	CcSEcCtD
Zaleplon—Feeling abnormal—Bleomycin—melanoma	0.000688	0.00143	CcSEcCtD
Zaleplon—Skin disorder—Temozolomide—melanoma	0.000684	0.00142	CcSEcCtD
Zaleplon—Hypotension—Carmustine—melanoma	0.000681	0.00141	CcSEcCtD
Zaleplon—Hyperhidrosis—Temozolomide—melanoma	0.000681	0.00141	CcSEcCtD
Zaleplon—GABRB2—head—melanoma	0.00068	0.0278	CbGeAlD
Zaleplon—GABRG2—head—melanoma	0.00068	0.0278	CbGeAlD
Zaleplon—Decreased appetite—Dactinomycin—melanoma	0.000677	0.0014	CcSEcCtD
Zaleplon—Anorexia—Temozolomide—melanoma	0.000671	0.00139	CcSEcCtD
Zaleplon—Pain—Dactinomycin—melanoma	0.000666	0.00138	CcSEcCtD
Zaleplon—Musculoskeletal discomfort—Carmustine—melanoma	0.000664	0.00138	CcSEcCtD
Zaleplon—Urticaria—Bleomycin—melanoma	0.000663	0.00138	CcSEcCtD
Zaleplon—Body temperature increased—Bleomycin—melanoma	0.00066	0.00137	CcSEcCtD
Zaleplon—Insomnia—Carmustine—melanoma	0.000659	0.00137	CcSEcCtD
Zaleplon—Hypoaesthesia—Docetaxel—melanoma	0.000656	0.00136	CcSEcCtD
Zaleplon—Paraesthesia—Carmustine—melanoma	0.000655	0.00136	CcSEcCtD
Zaleplon—Dyspnoea—Carmustine—melanoma	0.00065	0.00135	CcSEcCtD
Zaleplon—Oedema peripheral—Docetaxel—melanoma	0.00065	0.00135	CcSEcCtD
Zaleplon—Somnolence—Carmustine—melanoma	0.000648	0.00134	CcSEcCtD
Zaleplon—Feeling abnormal—Dactinomycin—melanoma	0.000642	0.00133	CcSEcCtD
Zaleplon—Musculoskeletal discomfort—Temozolomide—melanoma	0.000642	0.00133	CcSEcCtD
Zaleplon—Insomnia—Temozolomide—melanoma	0.000637	0.00132	CcSEcCtD
Zaleplon—Gastrointestinal pain—Dactinomycin—melanoma	0.000637	0.00132	CcSEcCtD
Zaleplon—Visual impairment—Docetaxel—melanoma	0.000635	0.00132	CcSEcCtD
Zaleplon—Decreased appetite—Carmustine—melanoma	0.000634	0.00131	CcSEcCtD
Zaleplon—Paraesthesia—Temozolomide—melanoma	0.000633	0.00131	CcSEcCtD
Zaleplon—Gastrointestinal disorder—Carmustine—melanoma	0.000629	0.0013	CcSEcCtD
Zaleplon—Dyspnoea—Temozolomide—melanoma	0.000628	0.0013	CcSEcCtD
Zaleplon—Somnolence—Temozolomide—melanoma	0.000626	0.0013	CcSEcCtD
Zaleplon—Pain—Carmustine—melanoma	0.000623	0.00129	CcSEcCtD
Zaleplon—Constipation—Carmustine—melanoma	0.000623	0.00129	CcSEcCtD
Zaleplon—GABRA2—head—melanoma	0.000621	0.0254	CbGeAlD
Zaleplon—Dyspepsia—Temozolomide—melanoma	0.00062	0.00129	CcSEcCtD
Zaleplon—Eye disorder—Docetaxel—melanoma	0.000616	0.00128	CcSEcCtD
Zaleplon—Body temperature increased—Dactinomycin—melanoma	0.000616	0.00128	CcSEcCtD
Zaleplon—Abdominal pain—Dactinomycin—melanoma	0.000616	0.00128	CcSEcCtD
Zaleplon—Decreased appetite—Temozolomide—melanoma	0.000612	0.00127	CcSEcCtD
Zaleplon—Gastrointestinal disorder—Temozolomide—melanoma	0.000608	0.00126	CcSEcCtD
Zaleplon—Pain—Temozolomide—melanoma	0.000602	0.00125	CcSEcCtD
Zaleplon—Constipation—Temozolomide—melanoma	0.000602	0.00125	CcSEcCtD
Zaleplon—Feeling abnormal—Carmustine—melanoma	0.000601	0.00125	CcSEcCtD
Zaleplon—GABRA1—head—melanoma	0.0006	0.0246	CbGeAlD
Zaleplon—Asthenia—Bleomycin—melanoma	0.000599	0.00124	CcSEcCtD
Zaleplon—Gastrointestinal pain—Carmustine—melanoma	0.000596	0.00124	CcSEcCtD
Zaleplon—Immune system disorder—Docetaxel—melanoma	0.000596	0.00123	CcSEcCtD
Zaleplon—Chills—Docetaxel—melanoma	0.000592	0.00123	CcSEcCtD
Zaleplon—Pruritus—Bleomycin—melanoma	0.000591	0.00122	CcSEcCtD
Zaleplon—Alopecia—Docetaxel—melanoma	0.000583	0.00121	CcSEcCtD
Zaleplon—Feeling abnormal—Temozolomide—melanoma	0.00058	0.0012	CcSEcCtD
Zaleplon—Mental disorder—Docetaxel—melanoma	0.000578	0.0012	CcSEcCtD
Zaleplon—Body temperature increased—Carmustine—melanoma	0.000576	0.00119	CcSEcCtD
Zaleplon—Abdominal pain—Carmustine—melanoma	0.000576	0.00119	CcSEcCtD
Zaleplon—Gastrointestinal pain—Temozolomide—melanoma	0.000576	0.00119	CcSEcCtD
Zaleplon—TSPO—head—melanoma	0.000575	0.0235	CbGeAlD
Zaleplon—Malnutrition—Docetaxel—melanoma	0.000574	0.00119	CcSEcCtD
Zaleplon—Dysgeusia—Docetaxel—melanoma	0.000562	0.00117	CcSEcCtD
Zaleplon—Urticaria—Temozolomide—melanoma	0.00056	0.00116	CcSEcCtD
Zaleplon—Asthenia—Dactinomycin—melanoma	0.000559	0.00116	CcSEcCtD
Zaleplon—Abdominal pain—Temozolomide—melanoma	0.000557	0.00115	CcSEcCtD
Zaleplon—Body temperature increased—Temozolomide—melanoma	0.000557	0.00115	CcSEcCtD
Zaleplon—Back pain—Docetaxel—melanoma	0.000555	0.00115	CcSEcCtD
Zaleplon—Anaemia—Docetaxel—melanoma	0.000531	0.0011	CcSEcCtD
Zaleplon—Rash—Bleomycin—melanoma	0.000527	0.00109	CcSEcCtD
Zaleplon—Dermatitis—Bleomycin—melanoma	0.000526	0.00109	CcSEcCtD
Zaleplon—Asthenia—Carmustine—melanoma	0.000523	0.00108	CcSEcCtD
Zaleplon—GABRB3—head—melanoma	0.000522	0.0214	CbGeAlD
Zaleplon—Syncope—Docetaxel—melanoma	0.000515	0.00107	CcSEcCtD
Zaleplon—Palpitations—Docetaxel—melanoma	0.000507	0.00105	CcSEcCtD
Zaleplon—Asthenia—Temozolomide—melanoma	0.000505	0.00105	CcSEcCtD
Zaleplon—Loss of consciousness—Docetaxel—melanoma	0.000504	0.00105	CcSEcCtD
Zaleplon—Pruritus—Temozolomide—melanoma	0.000498	0.00103	CcSEcCtD
Zaleplon—Nausea—Bleomycin—melanoma	0.000496	0.00103	CcSEcCtD
Zaleplon—Hypertension—Docetaxel—melanoma	0.000496	0.00103	CcSEcCtD
Zaleplon—Rash—Dactinomycin—melanoma	0.000491	0.00102	CcSEcCtD
Zaleplon—Chest pain—Docetaxel—melanoma	0.000489	0.00101	CcSEcCtD
Zaleplon—Arthralgia—Docetaxel—melanoma	0.000489	0.00101	CcSEcCtD
Zaleplon—Myalgia—Docetaxel—melanoma	0.000489	0.00101	CcSEcCtD
Zaleplon—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—melanoma	0.000485	0.00101	CcSEcCtD
Zaleplon—Dizziness—Carmustine—melanoma	0.000482	0.000999	CcSEcCtD
Zaleplon—Dry mouth—Docetaxel—melanoma	0.000478	0.000991	CcSEcCtD
Zaleplon—Confusional state—Docetaxel—melanoma	0.000472	0.000979	CcSEcCtD
Zaleplon—AOX1—lymph node—melanoma	0.000471	0.0193	CbGeAlD
Zaleplon—Oedema—Docetaxel—melanoma	0.000468	0.000971	CcSEcCtD
Zaleplon—Anaphylactic shock—Docetaxel—melanoma	0.000468	0.000971	CcSEcCtD
Zaleplon—Dizziness—Temozolomide—melanoma	0.000466	0.000966	CcSEcCtD
Zaleplon—Nausea—Dactinomycin—melanoma	0.000463	0.000959	CcSEcCtD
Zaleplon—Shock—Docetaxel—melanoma	0.000461	0.000955	CcSEcCtD
Zaleplon—Rash—Carmustine—melanoma	0.00046	0.000953	CcSEcCtD
Zaleplon—Nervous system disorder—Docetaxel—melanoma	0.000459	0.000952	CcSEcCtD
Zaleplon—Dermatitis—Carmustine—melanoma	0.000459	0.000952	CcSEcCtD
Zaleplon—Tachycardia—Docetaxel—melanoma	0.000457	0.000948	CcSEcCtD
Zaleplon—Headache—Carmustine—melanoma	0.000457	0.000947	CcSEcCtD
Zaleplon—Skin disorder—Docetaxel—melanoma	0.000455	0.000943	CcSEcCtD
Zaleplon—Anorexia—Docetaxel—melanoma	0.000447	0.000926	CcSEcCtD
Zaleplon—Rash—Temozolomide—melanoma	0.000444	0.000921	CcSEcCtD
Zaleplon—Dermatitis—Temozolomide—melanoma	0.000444	0.00092	CcSEcCtD
Zaleplon—Headache—Temozolomide—melanoma	0.000441	0.000915	CcSEcCtD
Zaleplon—Hypotension—Docetaxel—melanoma	0.000438	0.000907	CcSEcCtD
Zaleplon—GABRA2—lymph node—melanoma	0.000435	0.0178	CbGeAlD
Zaleplon—Nausea—Carmustine—melanoma	0.000433	0.000898	CcSEcCtD
Zaleplon—Musculoskeletal discomfort—Docetaxel—melanoma	0.000427	0.000885	CcSEcCtD
Zaleplon—Insomnia—Docetaxel—melanoma	0.000424	0.000878	CcSEcCtD
Zaleplon—Paraesthesia—Docetaxel—melanoma	0.000421	0.000872	CcSEcCtD
Zaleplon—Nausea—Temozolomide—melanoma	0.000418	0.000867	CcSEcCtD
Zaleplon—Dyspnoea—Docetaxel—melanoma	0.000418	0.000866	CcSEcCtD
Zaleplon—Somnolence—Docetaxel—melanoma	0.000416	0.000863	CcSEcCtD
Zaleplon—Dyspepsia—Docetaxel—melanoma	0.000412	0.000855	CcSEcCtD
Zaleplon—Decreased appetite—Docetaxel—melanoma	0.000407	0.000844	CcSEcCtD
Zaleplon—Gastrointestinal disorder—Docetaxel—melanoma	0.000404	0.000838	CcSEcCtD
Zaleplon—TSPO—lymph node—melanoma	0.000402	0.0165	CbGeAlD
Zaleplon—Pain—Docetaxel—melanoma	0.000401	0.00083	CcSEcCtD
Zaleplon—Constipation—Docetaxel—melanoma	0.000401	0.00083	CcSEcCtD
Zaleplon—Feeling abnormal—Docetaxel—melanoma	0.000386	0.0008	CcSEcCtD
Zaleplon—Gastrointestinal pain—Docetaxel—melanoma	0.000383	0.000794	CcSEcCtD
Zaleplon—Abdominal pain—Docetaxel—melanoma	0.00037	0.000768	CcSEcCtD
Zaleplon—Body temperature increased—Docetaxel—melanoma	0.00037	0.000768	CcSEcCtD
Zaleplon—Asthenia—Docetaxel—melanoma	0.000336	0.000697	CcSEcCtD
Zaleplon—Pruritus—Docetaxel—melanoma	0.000331	0.000687	CcSEcCtD
Zaleplon—Dizziness—Docetaxel—melanoma	0.00031	0.000642	CcSEcCtD
Zaleplon—Rash—Docetaxel—melanoma	0.000295	0.000612	CcSEcCtD
Zaleplon—Dermatitis—Docetaxel—melanoma	0.000295	0.000612	CcSEcCtD
Zaleplon—Headache—Docetaxel—melanoma	0.000293	0.000608	CcSEcCtD
Zaleplon—Nausea—Docetaxel—melanoma	0.000278	0.000577	CcSEcCtD
Zaleplon—GABRB2—Transmembrane transport of small molecules—SLC5A5—melanoma	1.04e-05	0.0014	CbGpPWpGaD
Zaleplon—AOX1—Metabolism—VCAN—melanoma	1.04e-05	0.0014	CbGpPWpGaD
Zaleplon—GABRA2—Transmission across Chemical Synapses—MDM2—melanoma	1.02e-05	0.00138	CbGpPWpGaD
Zaleplon—GABRB3—Transmission across Chemical Synapses—MDM2—melanoma	1.02e-05	0.00137	CbGpPWpGaD
Zaleplon—GABRG2—Transmission across Chemical Synapses—MDM2—melanoma	9.97e-06	0.00134	CbGpPWpGaD
Zaleplon—GABRB2—Neuronal System—BRAF—melanoma	9.97e-06	0.00134	CbGpPWpGaD
Zaleplon—GABRA1—SIDS Susceptibility Pathways—CXCL8—melanoma	9.94e-06	0.00134	CbGpPWpGaD
Zaleplon—GABRB3—BDNF signaling pathway—STAT3—melanoma	9.93e-06	0.00134	CbGpPWpGaD
Zaleplon—GABRB2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MAPK1—melanoma	9.91e-06	0.00134	CbGpPWpGaD
Zaleplon—AOX1—Disease—GAB2—melanoma	9.87e-06	0.00133	CbGpPWpGaD
Zaleplon—GABRA2—Transmembrane transport of small molecules—SLC5A5—melanoma	9.73e-06	0.00131	CbGpPWpGaD
Zaleplon—GABRB3—Transmembrane transport of small molecules—SLC5A5—melanoma	9.67e-06	0.0013	CbGpPWpGaD
Zaleplon—AOX1—Disease—FASN—melanoma	9.66e-06	0.0013	CbGpPWpGaD
Zaleplon—GABRA1—SIDS Susceptibility Pathways—CASP3—melanoma	9.52e-06	0.00128	CbGpPWpGaD
Zaleplon—GABRG2—Transmembrane transport of small molecules—SLC5A5—melanoma	9.49e-06	0.00128	CbGpPWpGaD
Zaleplon—GABRB3—BDNF signaling pathway—MAPK3—melanoma	9.49e-06	0.00128	CbGpPWpGaD
Zaleplon—GABRA2—Neuronal System—BRAF—melanoma	9.35e-06	0.00126	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—ACER3—melanoma	9.32e-06	0.00126	CbGpPWpGaD
Zaleplon—GABRA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MAPK1—melanoma	9.3e-06	0.00125	CbGpPWpGaD
Zaleplon—GABRB3—Neuronal System—BRAF—melanoma	9.29e-06	0.00125	CbGpPWpGaD
Zaleplon—AOX1—Disease—HDAC2—melanoma	9.28e-06	0.00125	CbGpPWpGaD
Zaleplon—AOX1—Disease—FOXO4—melanoma	9.28e-06	0.00125	CbGpPWpGaD
Zaleplon—AOX1—Disease—CXCR4—melanoma	9.28e-06	0.00125	CbGpPWpGaD
Zaleplon—GABRB3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MAPK1—melanoma	9.23e-06	0.00124	CbGpPWpGaD
Zaleplon—AOX1—Disease—CD44—melanoma	9.18e-06	0.00124	CbGpPWpGaD
Zaleplon—GABRA1—SIDS Susceptibility Pathways—CTNNB1—melanoma	9.17e-06	0.00124	CbGpPWpGaD
Zaleplon—GABRG2—Neuronal System—BRAF—melanoma	9.12e-06	0.00123	CbGpPWpGaD
Zaleplon—GABRG2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MAPK1—melanoma	9.07e-06	0.00122	CbGpPWpGaD
Zaleplon—GABRB3—BDNF signaling pathway—MAPK1—melanoma	9.03e-06	0.00122	CbGpPWpGaD
Zaleplon—GABRA1—SIDS Susceptibility Pathways—NFKB1—melanoma	8.9e-06	0.0012	CbGpPWpGaD
Zaleplon—AOX1—Metabolism—CYP17A1—melanoma	8.75e-06	0.00118	CbGpPWpGaD
Zaleplon—CYP3A4—Tryptophan metabolism—MDM2—melanoma	8.73e-06	0.00118	CbGpPWpGaD
Zaleplon—GABRA1—Transmission across Chemical Synapses—MDM2—melanoma	8.72e-06	0.00117	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—UGT2B10—melanoma	8.53e-06	0.00115	CbGpPWpGaD
Zaleplon—AOX1—Disease—AKT3—melanoma	8.47e-06	0.00114	CbGpPWpGaD
Zaleplon—GABRB2—Neuronal System—MDM2—melanoma	8.36e-06	0.00113	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—PLCB4—melanoma	8.31e-06	0.00112	CbGpPWpGaD
Zaleplon—GABRA1—Transmembrane transport of small molecules—SLC5A5—melanoma	8.3e-06	0.00112	CbGpPWpGaD
Zaleplon—AOX1—Metabolism—GNA11—melanoma	8.27e-06	0.00111	CbGpPWpGaD
Zaleplon—AOX1—Metabolism—FASN—melanoma	8.09e-06	0.00109	CbGpPWpGaD
Zaleplon—GABRA1—SIDS Susceptibility Pathways—VEGFA—melanoma	8.08e-06	0.00109	CbGpPWpGaD
Zaleplon—GABRA1—Neuronal System—BRAF—melanoma	7.97e-06	0.00107	CbGpPWpGaD
Zaleplon—GABRB2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—melanoma	7.96e-06	0.00107	CbGpPWpGaD
Zaleplon—AOX1—Metabolism—SLC5A5—melanoma	7.96e-06	0.00107	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—HS3ST5—melanoma	7.93e-06	0.00107	CbGpPWpGaD
Zaleplon—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MAPK1—melanoma	7.93e-06	0.00107	CbGpPWpGaD
Zaleplon—GABRB2—Transmembrane transport of small molecules—ABCB1—melanoma	7.91e-06	0.00107	CbGpPWpGaD
Zaleplon—GABRA2—Neuronal System—MDM2—melanoma	7.83e-06	0.00106	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—PIP4K2A—melanoma	7.81e-06	0.00105	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—SLC6A11—melanoma	7.81e-06	0.00105	CbGpPWpGaD
Zaleplon—GABRB3—Neuronal System—MDM2—melanoma	7.78e-06	0.00105	CbGpPWpGaD
Zaleplon—CYP3A4—Biological oxidations—CYP17A1—melanoma	7.72e-06	0.00104	CbGpPWpGaD
Zaleplon—AOX1—Metabolism—GNAQ—melanoma	7.68e-06	0.00103	CbGpPWpGaD
Zaleplon—AOX1—Metabolism—CD44—melanoma	7.68e-06	0.00103	CbGpPWpGaD
Zaleplon—GABRG2—Neuronal System—MDM2—melanoma	7.64e-06	0.00103	CbGpPWpGaD
Zaleplon—CYP3A4—Metapathway biotransformation—CYP17A1—melanoma	7.62e-06	0.00103	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—MTAP—melanoma	7.6e-06	0.00102	CbGpPWpGaD
Zaleplon—AOX1—Disease—ERBB4—melanoma	7.48e-06	0.00101	CbGpPWpGaD
Zaleplon—GABRA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—melanoma	7.46e-06	0.00101	CbGpPWpGaD
Zaleplon—GABRB2—Transmission across Chemical Synapses—MAPK1—melanoma	7.45e-06	0.001	CbGpPWpGaD
Zaleplon—GABRA2—Transmembrane transport of small molecules—ABCB1—melanoma	7.42e-06	0.000999	CbGpPWpGaD
Zaleplon—AOX1—Disease—CDKN2B—melanoma	7.41e-06	0.000999	CbGpPWpGaD
Zaleplon—GABRB3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—melanoma	7.41e-06	0.000999	CbGpPWpGaD
Zaleplon—GABRB3—Transmembrane transport of small molecules—ABCB1—melanoma	7.37e-06	0.000993	CbGpPWpGaD
Zaleplon—AOX1—Metabolism—CYP1B1—melanoma	7.37e-06	0.000992	CbGpPWpGaD
Zaleplon—GABRG2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—melanoma	7.28e-06	0.000981	CbGpPWpGaD
Zaleplon—GABRB3—BDNF signaling pathway—HRAS—melanoma	7.25e-06	0.000976	CbGpPWpGaD
Zaleplon—GABRG2—Transmembrane transport of small molecules—ABCB1—melanoma	7.24e-06	0.000975	CbGpPWpGaD
Zaleplon—AOX1—Disease—CD86—melanoma	7.17e-06	0.000966	CbGpPWpGaD
Zaleplon—GABRA2—Transmission across Chemical Synapses—MAPK1—melanoma	6.99e-06	0.000941	CbGpPWpGaD
Zaleplon—AOX1—Disease—FGF1—melanoma	6.95e-06	0.000937	CbGpPWpGaD
Zaleplon—GABRB3—Transmission across Chemical Synapses—MAPK1—melanoma	6.94e-06	0.000935	CbGpPWpGaD
Zaleplon—GABRA1—SIDS Susceptibility Pathways—TNF—melanoma	6.92e-06	0.000932	CbGpPWpGaD
Zaleplon—GABRG2—Transmission across Chemical Synapses—MAPK1—melanoma	6.82e-06	0.000918	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—LUM—melanoma	6.77e-06	0.000912	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—PHGDH—melanoma	6.77e-06	0.000912	CbGpPWpGaD
Zaleplon—AOX1—Disease—PDGFRA—melanoma	6.73e-06	0.000907	CbGpPWpGaD
Zaleplon—GABRA1—Neuronal System—MDM2—melanoma	6.68e-06	0.0009	CbGpPWpGaD
Zaleplon—AOX1—Disease—PRKCA—melanoma	6.67e-06	0.000898	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—HPSE—melanoma	6.64e-06	0.000895	CbGpPWpGaD
Zaleplon—AOX1—Disease—ERCC2—melanoma	6.61e-06	0.000891	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—CUBN—melanoma	6.52e-06	0.000878	CbGpPWpGaD
Zaleplon—AOX1—Disease—MAP2K2—melanoma	6.52e-06	0.000878	CbGpPWpGaD
Zaleplon—CYP3A4—Biological oxidations—CYP1B1—melanoma	6.5e-06	0.000876	CbGpPWpGaD
Zaleplon—CYP3A4—Metapathway biotransformation—CYP1B1—melanoma	6.41e-06	0.000864	CbGpPWpGaD
Zaleplon—GABRB3—BDNF signaling pathway—AKT1—melanoma	6.4e-06	0.000862	CbGpPWpGaD
Zaleplon—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—melanoma	6.36e-06	0.000857	CbGpPWpGaD
Zaleplon—GABRA1—Transmembrane transport of small molecules—ABCB1—melanoma	6.33e-06	0.000852	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—SDHD—melanoma	6.3e-06	0.000848	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—BSG—melanoma	6.3e-06	0.000848	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—CSPG4—melanoma	6.3e-06	0.000848	CbGpPWpGaD
Zaleplon—AOX1—Disease—HLA-A—melanoma	6.2e-06	0.000835	CbGpPWpGaD
Zaleplon—AOX1—Disease—TERT—melanoma	6.2e-06	0.000835	CbGpPWpGaD
Zaleplon—AOX1—Disease—RAC1—melanoma	6.18e-06	0.000832	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—GPAM—melanoma	6.1e-06	0.000822	CbGpPWpGaD
Zaleplon—AOX1—Metabolism—ABCB1—melanoma	6.07e-06	0.000817	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—PLCB4—melanoma	6.01e-06	0.000809	CbGpPWpGaD
Zaleplon—GABRB2—Transmission across Chemical Synapses—HRAS—melanoma	5.98e-06	0.000806	CbGpPWpGaD
Zaleplon—GABRA1—Transmission across Chemical Synapses—MAPK1—melanoma	5.96e-06	0.000803	CbGpPWpGaD
Zaleplon—AOX1—Disease—HIF1A—melanoma	5.93e-06	0.000798	CbGpPWpGaD
Zaleplon—GABRB2—Neuronal System—MAPK1—melanoma	5.71e-06	0.000769	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—SLC6A11—melanoma	5.65e-06	0.000761	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—PIP4K2A—melanoma	5.65e-06	0.000761	CbGpPWpGaD
Zaleplon—GABRA2—Transmission across Chemical Synapses—HRAS—melanoma	5.61e-06	0.000756	CbGpPWpGaD
Zaleplon—GABRA1—SIDS Susceptibility Pathways—IL6—melanoma	5.59e-06	0.000752	CbGpPWpGaD
Zaleplon—AOX1—Metabolism—PRKCA—melanoma	5.58e-06	0.000752	CbGpPWpGaD
Zaleplon—GABRB3—Transmission across Chemical Synapses—HRAS—melanoma	5.57e-06	0.000751	CbGpPWpGaD
Zaleplon—AOX1—Metabolism—ERCC2—melanoma	5.54e-06	0.000746	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—MTAP—melanoma	5.49e-06	0.00074	CbGpPWpGaD
Zaleplon—GABRG2—Transmission across Chemical Synapses—HRAS—melanoma	5.47e-06	0.000737	CbGpPWpGaD
Zaleplon—AOX1—Disease—NOS2—melanoma	5.39e-06	0.000726	CbGpPWpGaD
Zaleplon—GABRA2—Neuronal System—MAPK1—melanoma	5.35e-06	0.000721	CbGpPWpGaD
Zaleplon—AOX1—Disease—NOTCH1—melanoma	5.34e-06	0.000719	CbGpPWpGaD
Zaleplon—GABRB3—Neuronal System—MAPK1—melanoma	5.32e-06	0.000716	CbGpPWpGaD
Zaleplon—AOX1—Disease—CD80—melanoma	5.23e-06	0.000705	CbGpPWpGaD
Zaleplon—GABRG2—Neuronal System—MAPK1—melanoma	5.22e-06	0.000703	CbGpPWpGaD
Zaleplon—AOX1—Disease—KIT—melanoma	5.22e-06	0.000703	CbGpPWpGaD
Zaleplon—AOX1—Disease—APC—melanoma	5.22e-06	0.000703	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—PLA2G6—melanoma	5.19e-06	0.000699	CbGpPWpGaD
Zaleplon—AOX1—Disease—EGF—melanoma	5.16e-06	0.000695	CbGpPWpGaD
Zaleplon—GABRB2—Transmembrane transport of small molecules—ALB—melanoma	4.95e-06	0.000667	CbGpPWpGaD
Zaleplon—AOX1—Disease—BRAF—melanoma	4.91e-06	0.000661	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—PHGDH—melanoma	4.9e-06	0.00066	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—LUM—melanoma	4.9e-06	0.00066	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—HPSE—melanoma	4.8e-06	0.000647	CbGpPWpGaD
Zaleplon—GABRA1—Transmission across Chemical Synapses—HRAS—melanoma	4.78e-06	0.000644	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—CUBN—melanoma	4.71e-06	0.000635	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—VCAN—melanoma	4.66e-06	0.000627	CbGpPWpGaD
Zaleplon—GABRA2—Transmembrane transport of small molecules—ALB—melanoma	4.64e-06	0.000625	CbGpPWpGaD
Zaleplon—AOX1—Disease—MAP2K1—melanoma	4.62e-06	0.000622	CbGpPWpGaD
Zaleplon—GABRB3—Transmembrane transport of small molecules—ALB—melanoma	4.61e-06	0.000621	CbGpPWpGaD
Zaleplon—AOX1—Disease—PIK3CD—melanoma	4.59e-06	0.000618	CbGpPWpGaD
Zaleplon—GABRB2—Neuronal System—HRAS—melanoma	4.58e-06	0.000617	CbGpPWpGaD
Zaleplon—GABRA1—Neuronal System—MAPK1—melanoma	4.57e-06	0.000615	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—SDHD—melanoma	4.55e-06	0.000613	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—CSPG4—melanoma	4.55e-06	0.000613	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—BSG—melanoma	4.55e-06	0.000613	CbGpPWpGaD
Zaleplon—GABRG2—Transmembrane transport of small molecules—ALB—melanoma	4.53e-06	0.00061	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—GPAM—melanoma	4.41e-06	0.000594	CbGpPWpGaD
Zaleplon—AOX1—Disease—FGF2—melanoma	4.4e-06	0.000592	CbGpPWpGaD
Zaleplon—AOX1—Metabolism—PIK3CG—melanoma	4.37e-06	0.000589	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—ACER3—melanoma	4.33e-06	0.000584	CbGpPWpGaD
Zaleplon—GABRA2—Neuronal System—HRAS—melanoma	4.3e-06	0.000579	CbGpPWpGaD
Zaleplon—GABRB3—Neuronal System—HRAS—melanoma	4.27e-06	0.000575	CbGpPWpGaD
Zaleplon—AOX1—Metabolism—PPARG—melanoma	4.22e-06	0.000568	CbGpPWpGaD
Zaleplon—GABRG2—Neuronal System—HRAS—melanoma	4.19e-06	0.000565	CbGpPWpGaD
Zaleplon—AOX1—Disease—MDM2—melanoma	4.11e-06	0.000554	CbGpPWpGaD
Zaleplon—AOX1—Disease—ERBB2—melanoma	4.05e-06	0.000546	CbGpPWpGaD
Zaleplon—AOX1—Disease—PIK3CB—melanoma	4e-06	0.000539	CbGpPWpGaD
Zaleplon—AOX1—Disease—CD4—melanoma	3.99e-06	0.000538	CbGpPWpGaD
Zaleplon—AOX1—Disease—PTGS2—melanoma	3.96e-06	0.000534	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—UGT2B10—melanoma	3.96e-06	0.000534	CbGpPWpGaD
Zaleplon—GABRA1—Transmembrane transport of small molecules—ALB—melanoma	3.96e-06	0.000533	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—CYP17A1—melanoma	3.93e-06	0.000529	CbGpPWpGaD
Zaleplon—AOX1—Metabolism—PIK3CD—melanoma	3.84e-06	0.000518	CbGpPWpGaD
Zaleplon—AOX1—Metabolism—ALB—melanoma	3.8e-06	0.000511	CbGpPWpGaD
Zaleplon—AOX1—Disease—CDKN1B—melanoma	3.76e-06	0.000506	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—PLA2G6—melanoma	3.75e-06	0.000505	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—GNA11—melanoma	3.71e-06	0.0005	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—HS3ST5—melanoma	3.69e-06	0.000496	CbGpPWpGaD
Zaleplon—GABRA1—Neuronal System—HRAS—melanoma	3.67e-06	0.000494	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—FASN—melanoma	3.63e-06	0.000489	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—SLC5A5—melanoma	3.57e-06	0.000481	CbGpPWpGaD
Zaleplon—AOX1—Disease—CTNNB1—melanoma	3.55e-06	0.000478	CbGpPWpGaD
Zaleplon—AOX1—Disease—CDKN1A—melanoma	3.47e-06	0.000467	CbGpPWpGaD
Zaleplon—AOX1—Disease—PTEN—melanoma	3.46e-06	0.000466	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—GNAQ—melanoma	3.45e-06	0.000465	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—CD44—melanoma	3.45e-06	0.000465	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—VCAN—melanoma	3.37e-06	0.000454	CbGpPWpGaD
Zaleplon—AOX1—Metabolism—PIK3CB—melanoma	3.35e-06	0.000451	CbGpPWpGaD
Zaleplon—AOX1—Metabolism—PTGS2—melanoma	3.32e-06	0.000447	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—CYP1B1—melanoma	3.31e-06	0.000446	CbGpPWpGaD
Zaleplon—AOX1—Disease—STAT3—melanoma	3.09e-06	0.000416	CbGpPWpGaD
Zaleplon—AOX1—Disease—NRAS—melanoma	3.08e-06	0.000415	CbGpPWpGaD
Zaleplon—AOX1—Disease—MAPK3—melanoma	2.95e-06	0.000398	CbGpPWpGaD
Zaleplon—AOX1—Metabolism—PTEN—melanoma	2.9e-06	0.00039	CbGpPWpGaD
Zaleplon—AOX1—Disease—MYC—melanoma	2.87e-06	0.000387	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—CYP17A1—melanoma	2.84e-06	0.000383	CbGpPWpGaD
Zaleplon—AOX1—Disease—MAPK1—melanoma	2.81e-06	0.000379	CbGpPWpGaD
Zaleplon—AOX1—Disease—EGFR—melanoma	2.81e-06	0.000379	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—PLCB4—melanoma	2.79e-06	0.000376	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—ABCB1—melanoma	2.72e-06	0.000367	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—GNA11—melanoma	2.68e-06	0.000361	CbGpPWpGaD
Zaleplon—AOX1—Disease—KRAS—melanoma	2.66e-06	0.000358	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—SLC6A11—melanoma	2.63e-06	0.000354	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—PIP4K2A—melanoma	2.63e-06	0.000354	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—FASN—melanoma	2.63e-06	0.000354	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—SLC5A5—melanoma	2.58e-06	0.000348	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—MTAP—melanoma	2.55e-06	0.000344	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—PRKCA—melanoma	2.51e-06	0.000338	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—GNAQ—melanoma	2.49e-06	0.000336	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—CD44—melanoma	2.49e-06	0.000336	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—ERCC2—melanoma	2.49e-06	0.000335	CbGpPWpGaD
Zaleplon—AOX1—Disease—PIK3CA—melanoma	2.44e-06	0.000329	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—CYP1B1—melanoma	2.39e-06	0.000322	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—PHGDH—melanoma	2.28e-06	0.000307	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—LUM—melanoma	2.28e-06	0.000307	CbGpPWpGaD
Zaleplon—AOX1—Disease—HRAS—melanoma	2.26e-06	0.000304	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—HPSE—melanoma	2.23e-06	0.000301	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—CUBN—melanoma	2.19e-06	0.000295	CbGpPWpGaD
Zaleplon—AOX1—Disease—IL6—melanoma	2.16e-06	0.000291	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—SDHD—melanoma	2.12e-06	0.000285	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—CSPG4—melanoma	2.12e-06	0.000285	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—BSG—melanoma	2.12e-06	0.000285	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—GPAM—melanoma	2.05e-06	0.000276	CbGpPWpGaD
Zaleplon—AOX1—Metabolism—PIK3CA—melanoma	2.04e-06	0.000275	CbGpPWpGaD
Zaleplon—AOX1—Disease—AKT1—melanoma	1.99e-06	0.000268	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—ABCB1—melanoma	1.97e-06	0.000265	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—PIK3CG—melanoma	1.96e-06	0.000265	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—PPARG—melanoma	1.9e-06	0.000255	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—PRKCA—melanoma	1.81e-06	0.000244	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—ERCC2—melanoma	1.8e-06	0.000242	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—PLA2G6—melanoma	1.74e-06	0.000235	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—PIK3CD—melanoma	1.73e-06	0.000233	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—ALB—melanoma	1.7e-06	0.00023	CbGpPWpGaD
Zaleplon—AOX1—Metabolism—AKT1—melanoma	1.67e-06	0.000225	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—VCAN—melanoma	1.57e-06	0.000211	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—PIK3CB—melanoma	1.5e-06	0.000203	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—PTGS2—melanoma	1.49e-06	0.000201	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—PIK3CG—melanoma	1.42e-06	0.000191	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—PPARG—melanoma	1.37e-06	0.000185	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—CYP17A1—melanoma	1.32e-06	0.000178	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—PTEN—melanoma	1.3e-06	0.000175	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—PIK3CD—melanoma	1.25e-06	0.000168	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—GNA11—melanoma	1.25e-06	0.000168	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—ALB—melanoma	1.23e-06	0.000166	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—FASN—melanoma	1.22e-06	0.000164	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—SLC5A5—melanoma	1.2e-06	0.000162	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—GNAQ—melanoma	1.16e-06	0.000156	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—CD44—melanoma	1.16e-06	0.000156	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—CYP1B1—melanoma	1.11e-06	0.00015	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—PIK3CB—melanoma	1.09e-06	0.000147	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—PTGS2—melanoma	1.08e-06	0.000145	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—PTEN—melanoma	9.4e-07	0.000127	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—PIK3CA—melanoma	9.17e-07	0.000124	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—ABCB1—melanoma	9.16e-07	0.000123	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—PRKCA—melanoma	8.43e-07	0.000113	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—ERCC2—melanoma	8.36e-07	0.000113	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—AKT1—melanoma	7.49e-07	0.000101	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—PIK3CA—melanoma	6.63e-07	8.93e-05	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—PIK3CG—melanoma	6.6e-07	8.89e-05	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—PPARG—melanoma	6.37e-07	8.58e-05	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—PIK3CD—melanoma	5.8e-07	7.81e-05	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—ALB—melanoma	5.73e-07	7.71e-05	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—AKT1—melanoma	5.42e-07	7.3e-05	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—PIK3CB—melanoma	5.06e-07	6.81e-05	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—PTGS2—melanoma	5.01e-07	6.75e-05	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—PTEN—melanoma	4.37e-07	5.89e-05	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—PIK3CA—melanoma	3.08e-07	4.15e-05	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—AKT1—melanoma	2.52e-07	3.39e-05	CbGpPWpGaD
